Revolutionizing Antibody Discovery: An Animal-Free, High Affinity and Mechanically Stable Single-domain Antibody Platform

Our unique technology allows for the production of highly specific and stable single-domain antibodies (SdAbs) without the use of animals, making them a more ethical and sustainable option for your projects *
Coming soon: we are building the future for the next-generation of antibodies. Follow-us to discovery the full story!

Unique recombinant antibodies

Our technology is a powerful single-domain antibody (SdAb) engineering platform that allows us to display the genetic variant library and screen binders for desired properties.

We use innovative and state-of-the-art techniques for the selection of the desired molecules to identify new affinity binders. 

Our platform generates high affinity and mechanically stable SdAbs against virtually any antigen without the use of animals, making it a more ethical and sustainable option in the field of antibody discovery.

Discover more

Why our platform? 

Our generated SdAbs are small in size, easy to engineer, and possess a high stability and affinity to their cognate antigen. This makes them ideal for a variety of applications, such as in-vitro diagnostic kits, therapeutics, agrochemistry, and basic research.

Benefits of our discovery platform:  

  1. An animal-free approach antibody discovery, maturation & production. 
  2. Faster and efficient discovery methods against targets of interest
  3. Improved mechanical stability leads to increased potential in a wide range of applications
  4. Our technology allows us to discover antibodies against virtually any antigen
blue and black vinyl record


Traditional methods of producing antibodies, such as animal immunization, can be lengthy, expensive, and controversial. Our platform delivers antibodies with increased specificity, higher efficiency, and lower cost compared to traditional methods. 

In conclusion, our animal-free, single-domain antibody discovery platform offers a versatile and cost-effective solution for the production of recombinant antibodies against virtually any target. With its increased specificity, higher efficiency, and lower cost, our technology is a game changer in the market and is poised to revolutionize the way antibodies are discovered and produced.

person showing black and white compass


What should I do?

If you're interested in learning more about our technology and how it can benefit your business or research, please don't hesitate to contact us. We would be happy to provide more information and answer any questions you may have. Thank you for considering our technology as a solution for your antibody discovery needs. 

We look forward hearing from you!

Separate email addresses with a comma.